- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03668106
Effect of Different Sperm Processing Methods in ICSI Outcome.
Effect of Different Sperm Processing Methods ( Swim up, Zeta, Sperm Gradient Centrifugation ) in ICSI Outcome. "A Sperm DNA Perspective"
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
Qalubiya
-
Banha, Qalubiya, Egypt, 13512
- Ahmed Saad
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- unexplained infertile couples for 2 years
- age from 20 years old to 37 years old
Exclusion Criteria:
- endometriosis cases
- uterine factors
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: swim up method
Measure volume using a sterile 2 mL pipet.Transfer specimen from a plastic cup to a sterile 15 mL- conical centrifuge tube.
Gently mix the specimen with equal volume of Sperm Washing Media.
Centrifuge the tubes at 1500 rpm for 10 minutes.Carefully aspirate the supernatant without disturbing the pellet and resuspend the pellet in 50mcm of fresh washing medium, then place layer of 0.5 ml of washing medium gently on the surface.
Incubate the tubes at a 45° angle for 1 hour for swim-up in vertical rack in a 37°C incubator.
After the incubation period, aspirate the entire supernatant from the round bottom tube.
Aliquots of the detached sperm were analyzed by halosperm assay for DNA fragmentation another aliquots of same supernatant were used for ICSI then fertilization, division, blastulation, pregnancy and implantation rates were tabulated and statistically tested.
|
different sperm processing method for selcting most proper sperm for ICSI
|
Active Comparator: sperm gradient centrifugation
PureSperm gradients 40 % and 80 % were used for the experiment. All procedures were conducted under sterile conditions. Using a sterile pipette, 2.0 mL of the "lower layer" (80% PureSperm gradient) was transferred into a conical centrifuge tube. Using a new sterile pipette, 2.0 mL of the "upper layer" (40% PureSperm gradient) was gently dispensed on top of the lower layer. A liquefied semen sample was then placed on top of the upper layer and the tube was centrifuged for 20 minutes at 300g. The upper and lower layers were carefully aspirated without disturbing the pellet. Using a transfer pipette, 2-3 mL of Ham's F10 +10% HAS was added to the pellet and the resuspended pellet was centrifuged for 7 minutes at 300g. The supernatant was then removed and the pellet was suspended in a volume of 0.5 mL of Ham's F10 + FCS 10%. Aliquots of the detached sperm were dealt with like previous arm |
different sperm processing method for selcting most proper sperm for ICSI
|
Active Comparator: zeta method
sperm samples were diluted 5 million in 1 ml. To induce a positive charge, the tube was placed inside a latex glove up to the cap and grasping the cap, the tube was rotated two or three turns and rapidly pulled out. Each tube was kept at room temperature for 1 minute to allow adherence of the charged sperm to the wall of the centrifuge tube. Tubes were hold by the cap to avoid grounding of the tube. After 1 minute the tubes were centrifuged at 200g for 5 minutes. Then, the medium and pellet were discarded in order to discard non adhering sperm and other cells. The surface of tube was washed by 0.2ml of Ham's F10+ FCS 10% in order to neutralize the charge on the wall of the tube and detach the adhering sperm. The collected medium at the bottom of each tube was repipetted and used to rinse the wall of the same tube several times to increase the number of recovered sperm . Aliquots of the detached sperm were dealt with like previous arm |
different sperm processing method for selcting most proper sperm for ICSI
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sperm DNA fragmentation
Time Frame: 30 minutes
|
measure sperm integrity by halosperm assay
|
30 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Oocyte fertilization rate
Time Frame: day 1
|
no. of oocytes fertilized /total no. of oocytes
|
day 1
|
Blastulation rate
Time Frame: day 5
|
no of embryos blastulated / total no. of embryos
|
day 5
|
pregnancy rate
Time Frame: 15 days
|
no of pregnant cases\ all no. of cases
|
15 days
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Hawaa-4
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sperm DNA Fragmentation
-
Ganin Fertility CenterThe Cleveland Clinic; University of the Western CapeCompletedSperm DNA FragmentationEgypt
-
IVI MadridRecruitingSperm | Sperm DNA Fragmentation | Male Fertility | TelomeresSpain
-
Ganin Fertility CenterRecruitingInfertility | Sperm DNA FragmentationEgypt
-
University of California, San FranciscoCompletedInfertility | Fertility Disorders | Infertility, Male | Infertility Unexplained | Sperm DNA Fragmentation | Embryo QualityUnited States
-
Weill Medical College of Cornell UniversityRecruitingInfertility, Male | Sperm DNA FragmentationUnited States
-
Ganin Fertility CenterCompletedInfertility | Teratozoospermia | Sperm DNA FragmentationEgypt
-
Northwell HealthOrganonTerminatedSperm DNA Impact on ART OutcomesUnited States
-
Colorado Center for Reproductive MedicineTerminatedObserve Effect of Antioxidant on Sperm DNA FragmentionUnited States
-
CREA Medicina de la Reproducción SLRecruitingIntracytoplasmic Sperm Injection | Sperm | MicrofluidicsSpain
-
Instituto Valenciano de Infertilidad, IVI VALENCIAUniversity of BarcelonaCompleted
Clinical Trials on sperm processing method
-
Xuanwu Hospital, BeijingHebei Medical University; Thermogenesis Corp.UnknownPeripheral Arterial Disease | Critical Limb Ischemia | Buerger's DiseaseChina
-
CREA Medicina de la Reproducción SLRecruitingIntracytoplasmic Sperm Injection | Sperm | MicrofluidicsSpain
-
Royan InstituteCompletedInfertilityIran, Islamic Republic of
-
Nadezhda Women's Health HospitalEnrolling by invitation
-
Sapientiae InstituteTerminated
-
Instituto Valenciano de Infertilidad, IVI AlicanteIgenomixCompleted
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Instituto Valenciano de Infertilidad, IVI VALENCIAIVI MadridRecruitingInfertility, Male | Sperm Count, LowSpain
-
Centro de Infertilidad y Reproducción HumanaTerminated
-
FertilysInstitut national de la recherche scientifiqueTerminatedCovid19 | Infertility, MaleCanada